Premature Labor Treatment
Premature Labor Treatment market is segmented by players, region (country), by Type and by Applic ... Read More
Global C-X-C Chemokine Receptor Type 4 Market Research Report 2024
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global C-X-C Chemokine Receptor Type 4 Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 AM-3114
1.2.3 BL-8040
1.2.4 GMI-1359
1.2.5 HPH-112
1.2.6 Others
1.3 Market by Application
1.3.1 Global C-X-C Chemokine Receptor Type 4 Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Liver Cancer
1.3.3 Myocardial Infarction
1.3.4 Renal Cell Carcinoma
1.3.5 Stroke
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global C-X-C Chemokine Receptor Type 4 Market Perspective (2017-2028)
2.2 C-X-C Chemokine Receptor Type 4 Growth Trends by Region
2.2.1 C-X-C Chemokine Receptor Type 4 Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 C-X-C Chemokine Receptor Type 4 Historic Market Size by Region (2017-2022)
2.2.3 C-X-C Chemokine Receptor Type 4 Forecasted Market Size by Region (2023-2028)
2.3 C-X-C Chemokine Receptor Type 4 Market Dynamics
2.3.1 C-X-C Chemokine Receptor Type 4 Industry Trends
2.3.2 C-X-C Chemokine Receptor Type 4 Market Drivers
2.3.3 C-X-C Chemokine Receptor Type 4 Market Challenges
2.3.4 C-X-C Chemokine Receptor Type 4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top C-X-C Chemokine Receptor Type 4 Players by Revenue
3.1.1 Global Top C-X-C Chemokine Receptor Type 4 Players by Revenue (2017-2022)
3.1.2 Global C-X-C Chemokine Receptor Type 4 Revenue Market Share by Players (2017-2022)
3.2 Global C-X-C Chemokine Receptor Type 4 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by C-X-C Chemokine Receptor Type 4 Revenue
3.4 Global C-X-C Chemokine Receptor Type 4 Market Concentration Ratio
3.4.1 Global C-X-C Chemokine Receptor Type 4 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by C-X-C Chemokine Receptor Type 4 Revenue in 2021
3.5 C-X-C Chemokine Receptor Type 4 Key Players Head office and Area Served
3.6 Key Players C-X-C Chemokine Receptor Type 4 Product Solution and Service
3.7 Date of Enter into C-X-C Chemokine Receptor Type 4 Market
3.8 Mergers & Acquisitions, Expansion Plans
4 C-X-C Chemokine Receptor Type 4 Breakdown Data by Type
4.1 Global C-X-C Chemokine Receptor Type 4 Historic Market Size by Type (2017-2022)
4.2 Global C-X-C Chemokine Receptor Type 4 Forecasted Market Size by Type (2023-2028)
5 C-X-C Chemokine Receptor Type 4 Breakdown Data by Application
5.1 Global C-X-C Chemokine Receptor Type 4 Historic Market Size by Application (2017-2022)
5.2 Global C-X-C Chemokine Receptor Type 4 Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America C-X-C Chemokine Receptor Type 4 Market Size (2017-2028)
6.2 North America C-X-C Chemokine Receptor Type 4 Market Size by Country (2017-2022)
6.3 North America C-X-C Chemokine Receptor Type 4 Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe C-X-C Chemokine Receptor Type 4 Market Size (2017-2028)
7.2 Europe C-X-C Chemokine Receptor Type 4 Market Size by Country (2017-2022)
7.3 Europe C-X-C Chemokine Receptor Type 4 Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size (2017-2028)
8.2 Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size by Country (2017-2022)
8.3 Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America C-X-C Chemokine Receptor Type 4 Market Size (2017-2028)
9.2 Latin America C-X-C Chemokine Receptor Type 4 Market Size by Country (2017-2022)
9.3 Latin America C-X-C Chemokine Receptor Type 4 Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size (2017-2028)
10.2 Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size by Country (2017-2022)
10.3 Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 AdAlta Pty Ltd.
11.1.1 AdAlta Pty Ltd. Company Detail
11.1.2 AdAlta Pty Ltd. Business Overview
11.1.3 AdAlta Pty Ltd. C-X-C Chemokine Receptor Type 4 Introduction
11.1.4 AdAlta Pty Ltd. Revenue in C-X-C Chemokine Receptor Type 4 Business (2017-2022)
11.1.5 AdAlta Pty Ltd. Recent Development
11.2 Ambrx, Inc.
11.2.1 Ambrx, Inc. Company Detail
11.2.2 Ambrx, Inc. Business Overview
11.2.3 Ambrx, Inc. C-X-C Chemokine Receptor Type 4 Introduction
11.2.4 Ambrx, Inc. Revenue in C-X-C Chemokine Receptor Type 4 Business (2017-2022)
11.2.5 Ambrx, Inc. Recent Development
11.3 Anchor Therapeutics, Inc.
11.3.1 Anchor Therapeutics, Inc. Company Detail
11.3.2 Anchor Therapeutics, Inc. Business Overview
11.3.3 Anchor Therapeutics, Inc. C-X-C Chemokine Receptor Type 4 Introduction
11.3.4 Anchor Therapeutics, Inc. Revenue in C-X-C Chemokine Receptor Type 4 Business (2017-2022)
11.3.5 Anchor Therapeutics, Inc. Recent Development
11.4 Biokine Therapeutics Ltd.
11.4.1 Biokine Therapeutics Ltd. Company Detail
11.4.2 Biokine Therapeutics Ltd. Business Overview
11.4.3 Biokine Therapeutics Ltd. C-X-C Chemokine Receptor Type 4 Introduction
11.4.4 Biokine Therapeutics Ltd. Revenue in C-X-C Chemokine Receptor Type 4 Business (2017-2022)
11.4.5 Biokine Therapeutics Ltd. Recent Development
11.5 BioLineRx, Ltd.
11.5.1 BioLineRx, Ltd. Company Detail
11.5.2 BioLineRx, Ltd. Business Overview
11.5.3 BioLineRx, Ltd. C-X-C Chemokine Receptor Type 4 Introduction
11.5.4 BioLineRx, Ltd. Revenue in C-X-C Chemokine Receptor Type 4 Business (2017-2022)
11.5.5 BioLineRx, Ltd. Recent Development
11.6 Bristol-Myers Squibb Company
11.6.1 Bristol-Myers Squibb Company Company Detail
11.6.2 Bristol-Myers Squibb Company Business Overview
11.6.3 Bristol-Myers Squibb Company C-X-C Chemokine Receptor Type 4 Introduction
11.6.4 Bristol-Myers Squibb Company Revenue in C-X-C Chemokine Receptor Type 4 Business (2017-2022)
11.6.5 Bristol-Myers Squibb Company Recent Development
11.7 Eli Lilly and Company
11.7.1 Eli Lilly and Company Company Detail
11.7.2 Eli Lilly and Company Business Overview
11.7.3 Eli Lilly and Company C-X-C Chemokine Receptor Type 4 Introduction
11.7.4 Eli Lilly and Company Revenue in C-X-C Chemokine Receptor Type 4 Business (2017-2022)
11.7.5 Eli Lilly and Company Recent Development
11.8 Globavir Biosciences, Inc.
11.8.1 Globavir Biosciences, Inc. Company Detail
11.8.2 Globavir Biosciences, Inc. Business Overview
11.8.3 Globavir Biosciences, Inc. C-X-C Chemokine Receptor Type 4 Introduction
11.8.4 Globavir Biosciences, Inc. Revenue in C-X-C Chemokine Receptor Type 4 Business (2017-2022)
11.8.5 Globavir Biosciences, Inc. Recent Development
11.9 GlycoMimetics, Inc.
11.9.1 GlycoMimetics, Inc. Company Detail
11.9.2 GlycoMimetics, Inc. Business Overview
11.9.3 GlycoMimetics, Inc. C-X-C Chemokine Receptor Type 4 Introduction
11.9.4 GlycoMimetics, Inc. Revenue in C-X-C Chemokine Receptor Type 4 Business (2017-2022)
11.9.5 GlycoMimetics, Inc. Recent Development
11.10 NeED Pharma s.r.l.
11.10.1 NeED Pharma s.r.l. Company Detail
11.10.2 NeED Pharma s.r.l. Business Overview
11.10.3 NeED Pharma s.r.l. C-X-C Chemokine Receptor Type 4 Introduction
11.10.4 NeED Pharma s.r.l. Revenue in C-X-C Chemokine Receptor Type 4 Business (2017-2022)
11.10.5 NeED Pharma s.r.l. Recent Development
11.11 Pharis Biotec GmbH
11.11.1 Pharis Biotec GmbH Company Detail
11.11.2 Pharis Biotec GmbH Business Overview
11.11.3 Pharis Biotec GmbH C-X-C Chemokine Receptor Type 4 Introduction
11.11.4 Pharis Biotec GmbH Revenue in C-X-C Chemokine Receptor Type 4 Business (2017-2022)
11.11.5 Pharis Biotec GmbH Recent Development
11.12 Polyphor Ltd.
11.12.1 Polyphor Ltd. Company Detail
11.12.2 Polyphor Ltd. Business Overview
11.12.3 Polyphor Ltd. C-X-C Chemokine Receptor Type 4 Introduction
11.12.4 Polyphor Ltd. Revenue in C-X-C Chemokine Receptor Type 4 Business (2017-2022)
11.12.5 Polyphor Ltd. Recent Development
11.13 Sanofi
11.13.1 Sanofi Company Detail
11.13.2 Sanofi Business Overview
11.13.3 Sanofi C-X-C Chemokine Receptor Type 4 Introduction
11.13.4 Sanofi Revenue in C-X-C Chemokine Receptor Type 4 Business (2017-2022)
11.13.5 Sanofi Recent Development
11.14 TaiGen Biotechnology Co., Ltd.
11.14.1 TaiGen Biotechnology Co., Ltd. Company Detail
11.14.2 TaiGen Biotechnology Co., Ltd. Business Overview
11.14.3 TaiGen Biotechnology Co., Ltd. C-X-C Chemokine Receptor Type 4 Introduction
11.14.4 TaiGen Biotechnology Co., Ltd. Revenue in C-X-C Chemokine Receptor Type 4 Business (2017-2022)
11.14.5 TaiGen Biotechnology Co., Ltd. Recent Development
11.15 Upsher-Smith Laboratories, Inc.
11.15.1 Upsher-Smith Laboratories, Inc. Company Detail
11.15.2 Upsher-Smith Laboratories, Inc. Business Overview
11.15.3 Upsher-Smith Laboratories, Inc. C-X-C Chemokine Receptor Type 4 Introduction
11.15.4 Upsher-Smith Laboratories, Inc. Revenue in C-X-C Chemokine Receptor Type 4 Business (2017-2022)
11.15.5 Upsher-Smith Laboratories, Inc. Recent Development
11.16 X4 Pharmaceuticals, Inc.
11.16.1 X4 Pharmaceuticals, Inc. Company Detail
11.16.2 X4 Pharmaceuticals, Inc. Business Overview
11.16.3 X4 Pharmaceuticals, Inc. C-X-C Chemokine Receptor Type 4 Introduction
11.16.4 X4 Pharmaceuticals, Inc. Revenue in C-X-C Chemokine Receptor Type 4 Business (2017-2022)
11.16.5 X4 Pharmaceuticals, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global C-X-C Chemokine Receptor Type 4 Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of AM-3114
Table 3. Key Players of BL-8040
Table 4. Key Players of GMI-1359
Table 5. Key Players of HPH-112
Table 6. Key Players of Others
Table 7. Global C-X-C Chemokine Receptor Type 4 Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global C-X-C Chemokine Receptor Type 4 Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global C-X-C Chemokine Receptor Type 4 Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global C-X-C Chemokine Receptor Type 4 Market Share by Region (2017-2022)
Table 11. Global C-X-C Chemokine Receptor Type 4 Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global C-X-C Chemokine Receptor Type 4 Market Share by Region (2023-2028)
Table 13. C-X-C Chemokine Receptor Type 4 Market Trends
Table 14. C-X-C Chemokine Receptor Type 4 Market Drivers
Table 15. C-X-C Chemokine Receptor Type 4 Market Challenges
Table 16. C-X-C Chemokine Receptor Type 4 Market Restraints
Table 17. Global C-X-C Chemokine Receptor Type 4 Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global C-X-C Chemokine Receptor Type 4 Market Share by Players (2017-2022)
Table 19. Global Top C-X-C Chemokine Receptor Type 4 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in C-X-C Chemokine Receptor Type 4 as of 2021)
Table 20. Ranking of Global Top C-X-C Chemokine Receptor Type 4 Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by C-X-C Chemokine Receptor Type 4 Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players C-X-C Chemokine Receptor Type 4 Product Solution and Service
Table 24. Date of Enter into C-X-C Chemokine Receptor Type 4 Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global C-X-C Chemokine Receptor Type 4 Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global C-X-C Chemokine Receptor Type 4 Revenue Market Share by Type (2017-2022)
Table 28. Global C-X-C Chemokine Receptor Type 4 Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global C-X-C Chemokine Receptor Type 4 Revenue Market Share by Type (2023-2028)
Table 30. Global C-X-C Chemokine Receptor Type 4 Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global C-X-C Chemokine Receptor Type 4 Revenue Market Share by Application (2017-2022)
Table 32. Global C-X-C Chemokine Receptor Type 4 Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global C-X-C Chemokine Receptor Type 4 Revenue Market Share by Application (2023-2028)
Table 34. North America C-X-C Chemokine Receptor Type 4 Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America C-X-C Chemokine Receptor Type 4 Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe C-X-C Chemokine Receptor Type 4 Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe C-X-C Chemokine Receptor Type 4 Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America C-X-C Chemokine Receptor Type 4 Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America C-X-C Chemokine Receptor Type 4 Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size by Country (2023-2028) & (US$ Million)
Table 44. AdAlta Pty Ltd. Company Detail
Table 45. AdAlta Pty Ltd. Business Overview
Table 46. AdAlta Pty Ltd. C-X-C Chemokine Receptor Type 4 Product
Table 47. AdAlta Pty Ltd. Revenue in C-X-C Chemokine Receptor Type 4 Business (2017-2022) & (US$ Million)
Table 48. AdAlta Pty Ltd. Recent Development
Table 49. Ambrx, Inc. Company Detail
Table 50. Ambrx, Inc. Business Overview
Table 51. Ambrx, Inc. C-X-C Chemokine Receptor Type 4 Product
Table 52. Ambrx, Inc. Revenue in C-X-C Chemokine Receptor Type 4 Business (2017-2022) & (US$ Million)
Table 53. Ambrx, Inc. Recent Development
Table 54. Anchor Therapeutics, Inc. Company Detail
Table 55. Anchor Therapeutics, Inc. Business Overview
Table 56. Anchor Therapeutics, Inc. C-X-C Chemokine Receptor Type 4 Product
Table 57. Anchor Therapeutics, Inc. Revenue in C-X-C Chemokine Receptor Type 4 Business (2017-2022) & (US$ Million)
Table 58. Anchor Therapeutics, Inc. Recent Development
Table 59. Biokine Therapeutics Ltd. Company Detail
Table 60. Biokine Therapeutics Ltd. Business Overview
Table 61. Biokine Therapeutics Ltd. C-X-C Chemokine Receptor Type 4 Product
Table 62. Biokine Therapeutics Ltd. Revenue in C-X-C Chemokine Receptor Type 4 Business (2017-2022) & (US$ Million)
Table 63. Biokine Therapeutics Ltd. Recent Development
Table 64. BioLineRx, Ltd. Company Detail
Table 65. BioLineRx, Ltd. Business Overview
Table 66. BioLineRx, Ltd. C-X-C Chemokine Receptor Type 4 Product
Table 67. BioLineRx, Ltd. Revenue in C-X-C Chemokine Receptor Type 4 Business (2017-2022) & (US$ Million)
Table 68. BioLineRx, Ltd. Recent Development
Table 69. Bristol-Myers Squibb Company Company Detail
Table 70. Bristol-Myers Squibb Company Business Overview
Table 71. Bristol-Myers Squibb Company C-X-C Chemokine Receptor Type 4 Product
Table 72. Bristol-Myers Squibb Company Revenue in C-X-C Chemokine Receptor Type 4 Business (2017-2022) & (US$ Million)
Table 73. Bristol-Myers Squibb Company Recent Development
Table 74. Eli Lilly and Company Company Detail
Table 75. Eli Lilly and Company Business Overview
Table 76. Eli Lilly and Company C-X-C Chemokine Receptor Type 4 Product
Table 77. Eli Lilly and Company Revenue in C-X-C Chemokine Receptor Type 4 Business (2017-2022) & (US$ Million)
Table 78. Eli Lilly and Company Recent Development
Table 79. Globavir Biosciences, Inc. Company Detail
Table 80. Globavir Biosciences, Inc. Business Overview
Table 81. Globavir Biosciences, Inc. C-X-C Chemokine Receptor Type 4 Product
Table 82. Globavir Biosciences, Inc. Revenue in C-X-C Chemokine Receptor Type 4 Business (2017-2022) & (US$ Million)
Table 83. Globavir Biosciences, Inc. Recent Development
Table 84. GlycoMimetics, Inc. Company Detail
Table 85. GlycoMimetics, Inc. Business Overview
Table 86. GlycoMimetics, Inc. C-X-C Chemokine Receptor Type 4 Product
Table 87. GlycoMimetics, Inc. Revenue in C-X-C Chemokine Receptor Type 4 Business (2017-2022) & (US$ Million)
Table 88. GlycoMimetics, Inc. Recent Development
Table 89. NeED Pharma s.r.l. Company Detail
Table 90. NeED Pharma s.r.l. Business Overview
Table 91. NeED Pharma s.r.l. C-X-C Chemokine Receptor Type 4 Product
Table 92. NeED Pharma s.r.l. Revenue in C-X-C Chemokine Receptor Type 4 Business (2017-2022) & (US$ Million)
Table 93. NeED Pharma s.r.l. Recent Development
Table 94. Pharis Biotec GmbH Company Detail
Table 95. Pharis Biotec GmbH Business Overview
Table 96. Pharis Biotec GmbH C-X-C Chemokine Receptor Type 4Product
Table 97. Pharis Biotec GmbH Revenue in C-X-C Chemokine Receptor Type 4 Business (2017-2022) & (US$ Million)
Table 98. Pharis Biotec GmbH Recent Development
Table 99. Polyphor Ltd. Company Detail
Table 100. Polyphor Ltd. Business Overview
Table 101. Polyphor Ltd. C-X-C Chemokine Receptor Type 4Product
Table 102. Polyphor Ltd. Revenue in C-X-C Chemokine Receptor Type 4 Business (2017-2022) & (US$ Million)
Table 103. Polyphor Ltd. Recent Development
Table 104. Sanofi Company Detail
Table 105. Sanofi Business Overview
Table 106. Sanofi C-X-C Chemokine Receptor Type 4Product
Table 107. Sanofi Revenue in C-X-C Chemokine Receptor Type 4 Business (2017-2022) & (US$ Million)
Table 108. Sanofi Recent Development
Table 109. TaiGen Biotechnology Co., Ltd. Company Detail
Table 110. TaiGen Biotechnology Co., Ltd. Business Overview
Table 111. TaiGen Biotechnology Co., Ltd. C-X-C Chemokine Receptor Type 4Product
Table 112. TaiGen Biotechnology Co., Ltd. Revenue in C-X-C Chemokine Receptor Type 4 Business (2017-2022) & (US$ Million)
Table 113. TaiGen Biotechnology Co., Ltd. Recent Development
Table 114. Upsher-Smith Laboratories, Inc. Company Detail
Table 115. Upsher-Smith Laboratories, Inc. Business Overview
Table 116. Upsher-Smith Laboratories, Inc. C-X-C Chemokine Receptor Type 4Product
Table 117. Upsher-Smith Laboratories, Inc. Revenue in C-X-C Chemokine Receptor Type 4 Business (2017-2022) & (US$ Million)
Table 118. Upsher-Smith Laboratories, Inc. Recent Development
Table 119. X4 Pharmaceuticals, Inc. Company Detail
Table 120. X4 Pharmaceuticals, Inc. Business Overview
Table 121. X4 Pharmaceuticals, Inc. C-X-C Chemokine Receptor Type 4Product
Table 122. X4 Pharmaceuticals, Inc. Revenue in C-X-C Chemokine Receptor Type 4 Business (2017-2022) & (US$ Million)
Table 123. X4 Pharmaceuticals, Inc. Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global C-X-C Chemokine Receptor Type 4 Market Share by Type: 2021 VS 2028
Figure 2. AM-3114 Features
Figure 3. BL-8040 Features
Figure 4. GMI-1359 Features
Figure 5. HPH-112 Features
Figure 6. Others Features
Figure 7. Global C-X-C Chemokine Receptor Type 4 Market Share by Application in 2021 & 2028
Figure 8. Liver Cancer Case Studies
Figure 9. Myocardial Infarction Case Studies
Figure 10. Renal Cell Carcinoma Case Studies
Figure 11. Stroke Case Studies
Figure 12. Others Case Studies
Figure 13. C-X-C Chemokine Receptor Type 4 Report Years Considered
Figure 14. Global C-X-C Chemokine Receptor Type 4 Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 15. Global C-X-C Chemokine Receptor Type 4 Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global C-X-C Chemokine Receptor Type 4 Market Share by Region: 2021 VS 2028
Figure 17. Global C-X-C Chemokine Receptor Type 4 Market Share by Players in 2021
Figure 18. Global Top C-X-C Chemokine Receptor Type 4 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in C-X-C Chemokine Receptor Type 4 as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by C-X-C Chemokine Receptor Type 4 Revenue in 2021
Figure 20. North America C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. North America C-X-C Chemokine Receptor Type 4 Market Share by Country (2017-2028)
Figure 22. United States C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe C-X-C Chemokine Receptor Type 4 Market Share by Country (2017-2028)
Figure 26. Germany C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Share by Region (2017-2028)
Figure 34. China C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Japan C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. South Korea C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Southeast Asia C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. India C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Australia C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America C-X-C Chemokine Receptor Type 4 Market Share by Country (2017-2028)
Figure 42. Mexico C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Brazil C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Share by Country (2017-2028)
Figure 46. Turkey C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Saudi Arabia C-X-C Chemokine Receptor Type 4 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. AdAlta Pty Ltd. Revenue Growth Rate in C-X-C Chemokine Receptor Type 4 Business (2017-2022)
Figure 49. Ambrx, Inc. Revenue Growth Rate in C-X-C Chemokine Receptor Type 4 Business (2017-2022)
Figure 50. Anchor Therapeutics, Inc. Revenue Growth Rate in C-X-C Chemokine Receptor Type 4 Business (2017-2022)
Figure 51. Biokine Therapeutics Ltd. Revenue Growth Rate in C-X-C Chemokine Receptor Type 4 Business (2017-2022)
Figure 52. BioLineRx, Ltd. Revenue Growth Rate in C-X-C Chemokine Receptor Type 4 Business (2017-2022)
Figure 53. Bristol-Myers Squibb Company Revenue Growth Rate in C-X-C Chemokine Receptor Type 4 Business (2017-2022)
Figure 54. Eli Lilly and Company Revenue Growth Rate in C-X-C Chemokine Receptor Type 4 Business (2017-2022)
Figure 55. Globavir Biosciences, Inc. Revenue Growth Rate in C-X-C Chemokine Receptor Type 4 Business (2017-2022)
Figure 56. GlycoMimetics, Inc. Revenue Growth Rate in C-X-C Chemokine Receptor Type 4 Business (2017-2022)
Figure 57. NeED Pharma s.r.l. Revenue Growth Rate in C-X-C Chemokine Receptor Type 4 Business (2017-2022)
Figure 58. Pharis Biotec GmbH Revenue Growth Rate in C-X-C Chemokine Receptor Type 4 Business (2017-2022)
Figure 59. Polyphor Ltd. Revenue Growth Rate in C-X-C Chemokine Receptor Type 4 Business (2017-2022)
Figure 60. Sanofi Revenue Growth Rate in C-X-C Chemokine Receptor Type 4 Business (2017-2022)
Figure 61. TaiGen Biotechnology Co., Ltd. Revenue Growth Rate in C-X-C Chemokine Receptor Type 4 Business (2017-2022)
Figure 62. Upsher-Smith Laboratories, Inc. Revenue Growth Rate in C-X-C Chemokine Receptor Type 4 Business (2017-2022)
Figure 63. X4 Pharmaceuticals, Inc. Revenue Growth Rate in C-X-C Chemokine Receptor Type 4 Business (2017-2022)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AdAlta Pty Ltd. Ambrx, Inc. Anchor Therapeutics, Inc. Biokine Therapeutics Ltd. BioLineRx, Ltd. Bristol-Myers Squibb Company Eli Lilly and Company Globavir Biosciences, Inc. GlycoMimetics, Inc. NeED Pharma s.r.l. Pharis Biotec GmbH Polyphor Ltd. Sanofi TaiGen Biotechnology Co., Ltd. Upsher-Smith Laboratories, Inc. X4 Pharmaceuticals, Inc.